Mallinckrodt Aktie - MNK

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

0,75

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

0,75

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Mallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday, March 13, 2025

Mallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday...

Mallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial Results

Mallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial Results PR Newswire DUBLIN, Feb. 27...

Mallinckrodt Completes Divestiture of Therakos® Business

Mallinckrodt Completes Divestiture of Therakos® Business PR Newswire DUBLIN, Dec. 2, 2024 Net Proceeds to...

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome...

Mallinckrodt to Present at Jefferies London Healthcare Conference

Mallinckrodt to Present at Jefferies London Healthcare Conference PR Newswire DUBLIN, Nov. 14, 2024 DUBLIN...

Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance

Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance PR...

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for...

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at the American College of Gastroenterology (ACG) Annual Meeting

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal...

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome...

Mallinckrodt to Report Earnings Results for Third Quarter 2024

Mallinckrodt to Report Earnings Results for Third Quarter 2024 PR Newswire DUBLIN, Oct. 24, 2024 DUBLIN, Oct...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MNK - Frequently Asked Questions (FAQ)

What is the current Mallinckrodt share price?

The current share price of Mallinckrodt is US$ 0,75

What is the 1 year trading range for Mallinckrodt share price?

Mallinckrodt has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
FTKFlotek Industries Inc	US$ 8,745 (18,02%)	556,69k
IONQIonQ Inc	US$ 21,82 (16,68%)	27,25M
CXMSprinklr Inc	US$ 9,42 (16,58%)	7,01M
SEISolaris Energy Infrastructure Inc	US$ 25,27 (13,68%)	2,96M
CHGGChegg Inc	US$ 0,8678 (12,42%)	3,12M
DTCSolo Brands Inc	US$ 0,2431 (-62,89%)	6,94M
HLLYHolley Inc	US$ 2,45 (-17,79%)	1,12M
MATVMativ Holdings Inc	US$ 5,86 (-14,70%)	3,92M
CNFCNFinance Holdings Limited	US$ 0,8701 (-14,70%)	87,4k
NOVASunnova Energy International Inc	US$ 0,3662 (-13,86%)	38,27M
FFord Motor Company	US$ 9,59 (-1,03%)	129,96M
NIONIO Inc	US$ 5,105 (-2,20%)	87,32M
QBTSD Wave Quantum Inc	US$ 5,87 (9,11%)	72,83M
TAT&T Inc	US$ 25,72 (-1,11%)	62,38M
NUNu Holdings Ltd	US$ 10,895 (2,78%)	51,72M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Mallinckrodt Plc (MNK) Börsenkurse

Mallinckrodt Plc (MNK)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

MNK Neueste Nachrichten

Mallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday, March 13, 2025

Mallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial Results

Mallinckrodt Completes Divestiture of Therakos® Business

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Mallinckrodt to Present at Jefferies London Healthcare Conference

Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at the American College of Gastroenterology (ACG) Annual Meeting

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024

Mallinckrodt to Report Earnings Results for Third Quarter 2024

Mallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday, March 13, 2025

Mallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial Results

Mallinckrodt Completes Divestiture of Therakos® Business

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Mallinckrodt to Present at Jefferies London Healthcare Conference

Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at the American College of Gastroenterology (ACG) Annual Meeting

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024

Mallinckrodt to Report Earnings Results for Third Quarter 2024

Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. Hospitals

Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector

MNK - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS